TRML(Delisted)
Tourmaline Bio·NASDAQ
--
--(--)
Tourmaline Bio (TRML) Financial Statements
Tourmaline Bio (TRML) Cash Flow Statement
During Q2 2025, Tourmaline Bio (TRML) generated -20.26M in cash flow from operating activities, 16.30M from investing activities, and 54.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | TTM |
|---|
Start Date | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | -- |
End Date | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -5.24M -- | -9.05M -72.55% | -16.28M -79.95% | -3.79M +76.71% | -5.40M -- | -9.35M -- | -14.92M -293.64% | -18.01M -- | -23.44M -334.47% | -20.89M -123.34% | -21.68M -45.27% | -20.26M -12.53% | -86.28M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -5.59M -- | -12.90M -- | -13.31M -- | -17.49M -- | -20.18M -260.88% | -22.23M -72.34% | -22.97M -72.56% | -23.09M -32.05% | -88.47M -- |
Depreciation and Amortization | 92.00K -- | 135.00K +46.74% | 297.00K +120.00% | 6.00K -97.98% | 9.00K -- | 11.00K -- | 10.00K +66.67% | 10.00K -- | 10.00K +11.11% | 9.00K -18.18% | 12.00K +20.00% | 12.00K +20.00% | 43.00K -- |
Stock-based Compensation | -- -- | -- -- | -- -- | -- -- | 706.00K -- | 4.25M -- | 1.39M -- | 1.79M -- | 1.68M +138.10% | 1.74M -59.21% | 2.27M +63.76% | 2.47M +37.84% | 8.15M -- |
Change in Working Capital | -561.00K -- | -1.27M -126.56% | -580.00K +54.37% | 3.28M +665.52% | -547.00K -- | 549.00K -- | -1.35M -141.25% | -33.00K -- | -2.39M -336.38% | 2.82M +414.39% | 388.00K +128.68% | 1.26M +3921.21% | 2.09M -- |
Change in Accounts Payable | -- -- | -- -- | -- -- | -- -- | -251.00K -- | -595.00K -- | 866.00K -- | 450.00K -- | -333.00K -32.67% | 1.45M +344.37% | -1.35M -255.77% | 740.00K +64.44% | 512.00K -- |
Change in Other Working Capital | -- -- | -- -- | -- -- | -- -- | -296.00K -- | 1.14M -- | -2.22M -- | -483.00K -- | -2.05M -593.92% | 1.37M +19.76% | 1.74M +178.28% | 521.00K +207.87% | 1.57M -- |
Other Non-cash Adjustments | -- -- | -- -- | -- -- | -- -- | 27.00K -- | -1.26M -- | -1.66M -- | -2.29M -- | -2.57M -9622.22% | -3.22M -154.70% | -1.38M +16.60% | -911.00K +60.15% | -8.09M -- |
Net Cash Flows from Investing Activities | -19.45M -- | 1.33M +106.84% | 20.43M +1435.86% | -24.00K -100.12% | -17.00K -- | 3.89M -- | -188.87M -786854.17% | -10.13M -- | -11.70M -68694.12% | 16.39M +320.90% | 25.94M +113.73% | 16.30M +260.92% | 46.94M -- |
Change in PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -17.00K -- | -2.00K -- | 0 -- | 0 -- | 0 +100.00% | -9.00K -350.00% | -9.00K -- | -7.00K -- | -25.00K -- |
Purchase of PPE and Intangible Assets | 349.00K -- | 187.00K -46.42% | 1.34M +617.11% | 24.00K -98.21% | 17.00K -- | 2.00K -- | 0 -100.00% | 0 -- | 0 -100.00% | 9.00K +350.00% | 9.00K -- | 7.00K -- | 25.00K -- |
Change in Investments | -- -- | -- -- | -- -- | -- -- | 0 -- | 3.90M -- | -188.87M -- | -10.13M -- | -11.70M -- | 16.40M +320.92% | 25.95M +113.74% | 16.31M +260.99% | 46.96M -- |
Decrease in Investments | -- -- | -- -- | -- -- | -- -- | 0 -- | 20.50M -- | 27.00M -- | 32.40M -- | 76.35M -- | 36.09M +76.05% | 111.11M +311.53% | 56.76M +75.20% | 280.32M -- |
Increase in Investments | 19.11M -- | 34.30M +79.51% | 39.98M +16.58% | 0 -100.00% | 0 -- | 16.60M -- | 215.87M -- | 42.53M -- | 88.05M -- | 19.69M +18.59% | 85.16M -60.55% | 40.45M -4.88% | 233.35M -- |
Net Cash Flows from Financing Activities | -- -- | 17.00K -- | 30.00K +76.47% | 0 -100.00% | -3.62M -- | 68.14M -- | 161.35M -- | 0 -- | -1.00K +99.97% | -3.00K -100.00% | 562.00K -99.65% | 54.00K -- | 612.00K -- |
Change in Debt | -- -- | -- -- | -- -- | -- -- | -- -- | 70.47M -- | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- |
Change in Capital Stock | -- -- | 123.00K -- | 131.00K +6.50% | 0 -100.00% | -234.00K -- | 0 -- | 161.35M -- | 0 -- | -1.00K +99.57% | -3.00K -- | 562.00K -99.65% | 54.00K -- | 612.00K -- |
Increase in Capital Stock | -- -- | 123.00K -- | 131.00K +6.50% | 0 -100.00% | -234.00K -- | 0 -- | 161.35M -- | 0 -- | 0 +100.00% | 0 -- | 569.00K -99.65% | 54.00K -- | 623.00K -- |
Decrease in Capital Stock | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | 0 -- | 0 -- | 1.00K -- | 3.00K -- | 7.00K -- | 0 -- | 11.00K -- |
Other Financing Activities | -- -- | -- -- | -- -- | -- -- | -3.39M -- | -2.33M -- | -- -- | -- -- | 0 +100.00% | 0 +100.00% | -- -- | -- -- | -- -- |
Net Increase in Cash and Cash Equivalents | -24.70M -- | -7.70M +68.82% | 4.18M +154.25% | -3.81M -191.33% | -9.04M -- | 62.68M -- | -42.44M -1012.45% | -28.14M -- | -35.14M -288.89% | -4.50M -107.18% | 4.82M +111.37% | -3.91M +86.11% | -38.73M -- |
Cash and Cash Equivalents at Beginning of Period | 38.98M -- | 17.59M -54.87% | 18.61M +5.83% | 8.47M -54.48% | 87.31M -- | 78.27M -- | 140.95M +1563.36% | 98.51M -- | 70.38M -19.39% | 35.23M -54.98% | 30.73M -78.20% | 35.56M -63.91% | 171.90M -- |
Cash and Cash Equivalents at End of Period | 14.28M -- | 9.89M -30.75% | 22.79M +130.47% | 4.66M -79.56% | 78.27M -- | 140.95M -- | 98.51M +2014.47% | 70.38M -- | 35.23M -54.98% | 30.73M -78.20% | 35.56M -63.91% | 31.65M -55.03% | 133.18M -- |
You can ask Aime
No Data
